Literature DB >> 25172622

Hypertensive pregnancy disorders and future renal disease.

Steven Wagner1, Iasmina Craici.   

Abstract

Hypertensive pregnancy disorders affect approximately 6 to 8 % of otherwise normal pregnancies. A growing body of evidence links these disorders with the future development of hypertension, coronary disease, cerebrovascular disease, and peripheral arterial disease. Larger studies associating hypertensive pregnancy to future development of renal disease have been lacking until recently, with publication of several compelling studies in the last 5 years. In this review, we will focus on the recent evidence associating hypertensive pregnancy disorders with the future development of chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as the development of microalbuminuria. We will also attempt to answer whether these renal risks are due to direct effects of hypertension during pregnancy, or whether they are due to shared environmental and genetic risk factors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172622     DOI: 10.1007/s11906-014-0484-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  30 in total

1.  Impaired vascular dilatation in women with a history of pre-eclampsia.

Authors:  Katja H Lampinen; Mats Rönnback; Risto J Kaaja; Per-Henrik Groop
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

2.  Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy.

Authors:  Tracey L Weissgerber; Stephen T Turner; Kent R Bailey; Thomas H Mosley; Sharon L R Kardia; Heather J Wiste; Virginia M Miller; Iftikhar J Kullo; Vesna D Garovic
Journal:  Atherosclerosis       Date:  2013-04-18       Impact factor: 5.162

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

4.  Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women.

Authors:  D Gordin; V Hiilesmaa; J Fagerudd; M Rönnback; C Forsblom; R Kaaja; K Teramo; P-H Groop
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

5.  What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia.

Authors:  R A North; D Simmons; D Barnfather; M Upjohn
Journal:  Aust N Z J Obstet Gynaecol       Date:  1996-08       Impact factor: 2.100

6.  Microalbuminuria after pregnancy complicated by pre-eclampsia.

Authors:  J Bar; B Kaplan; C Wittenberg; A Erman; G Boner; Z Ben-Rafael; M Hod
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

7.  Hypertension in pregnancy as a risk factor for cardiovascular disease later in life.

Authors:  Vesna D Garovic; Kent R Bailey; Eric Boerwinkle; Steven C Hunt; Alan B Weder; David Curb; Thomas H Mosley; Heather J Wiste; Stephen T Turner
Journal:  J Hypertens       Date:  2010-04       Impact factor: 4.844

8.  Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study.

Authors:  Iasmina M Craici; Steven J Wagner; Kent R Bailey; Patrick D Fitz-Gibbon; Christina M Wood-Wentz; Stephen T Turner; Suzanne R Hayman; Wendy M White; Brian C Brost; Carl H Rose; Joseph P Grande; Vesna D Garovic
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

9.  Preeclampsia and prevalence of microalbuminuria 10 years later.

Authors:  Miriam Kristine Sandvik; Stein Hallan; Einar Svarstad; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

10.  Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury.

Authors:  Wendy M White; Angelica T Garrett; Iasmina M Craici; Steven J Wagner; Patrick D Fitz-Gibbon; Kim A Butters; Brian C Brost; Carl H Rose; Joseph P Grande; Vesna D Garovic
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more
  1 in total

Review 1.  Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.

Authors:  Xin Zhou; Jian-Min Niu; Wen-Jie Ji; Zhuoli Zhang; Peizhong P Wang; Xue-Feng B Ling; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.